drugset / Trial / NCT02186769
An Randomized Open-Label PK Study of LY03004 Compared to Risperdal® Consta® in Stable Patients With Schizophrenia or Schizoaffective Disorder
RandomizedParallel-groupOpen-labelTreatment
Summary
A review of the amount of drug in your blood over time.
Timeline
- Start
- 2014-07
- Primary completion
- 2015-04
- Completion
- 2015-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Risperidone | Other / unclassified | 25 mg | Intramuscular |
| Comparator | Risperidone | Other / unclassified | 50 mg | Intramuscular |